Status:
RECRUITING
Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder
Lead Sponsor:
Loma Linda University
Collaborating Sponsors:
Autism Speaks
Conditions:
Central Auditory Processing Disorder
Autism Spectrum Disorder
Eligibility:
All Genders
6-17 years
Brief Summary
The proposed study aims to understand poor sleep as a possible cause to CAPD in children and adolescents with ASD (ASD+) compared to ASD youth without CAPD (ASD-), using both caregiver-report and obje...
Detailed Description
Participation will involve one assessment session approximating 4 hours including administration of neurocognitive and socioemotional measures by trained research staff. The research team then will de...
Eligibility Criteria
Inclusion
- Have diagnosis of Autism Spectrum Disorder confirmed by the Autism Diagnostic Observation Schedule and the Social Communication Questionnaire, Lifetime Version which will be filled by the parent
- IQ of 50 or higher on the Abbreviated Battery IQ Score
Exclusion
- No confirmed diagnosis of Autism Spectrum Disorder
- History of sleep apnea
- History of restless leg syndrome
- History of any neurological disorders (e.g., seizures, tumors, etc.)
- Significant substance use in the past six months
- Inpatient hospitalization in the past three months-period
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06059352
Start Date
November 1 2023
End Date
November 1 2025
Last Update
January 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Health
Loma Linda, California, United States, 92350